PSYB:F PSYBIO THERAP. (SUB.VT.)

EUR 0.00 0.00 0
Icon

PSYBIO THERAP. (SUB.VT.) (PSYB:F) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.00

0.00 (0.00)%

EUR 0.87M

2.00K

N/A

N/A

Icon

PSYB:F

PSYBIO THERAP. (SUB.VT.) (EUR)
COMMON STOCK | F
EUR 0.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.87M

N/A

EUR 0.00

PSYBIO THERAP. (SUB.VT.) (PSYB:F) Stock Forecast

N/A

Based on the PSYBIO THERAP. (SUB.VT.) stock forecast from 0 analysts, the average analyst target price for PSYBIO THERAP. (SUB.VT.) is not available over the next 12 months. PSYBIO THERAP. (SUB.VT.)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of PSYBIO THERAP. (SUB.VT.) is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, PSYBIO THERAP. (SUB.VT.)’s stock price was EUR 0.00. PSYBIO THERAP. (SUB.VT.)’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -98.18% over the last year.

No recent analyst target price found for PSYBIO THERAP. (SUB.VT.)
No recent average analyst rating found for PSYBIO THERAP. (SUB.VT.)

Company Overview PSYBIO THERAP. (SUB.VT.)

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as...Read More

N/A

N/A

0

December

EUR

Germany

Adjusted Closing Price for PSYBIO THERAP. (SUB.VT.) (PSYB:F)

Loading...

Unadjusted Closing Price for PSYBIO THERAP. (SUB.VT.) (PSYB:F)

Loading...

Share Trading Volume for PSYBIO THERAP. (SUB.VT.) Shares

Loading...

Compare Performance of PSYBIO THERAP. (SUB.VT.) Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PSYB:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To PSYBIO THERAP. (SUB.VT.) (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOVA:F
Novo Nordisk A/S 0.00 (0.00%) EUR408.54B 40.80 3.51

ETFs Containing PSYB

Symbol Name PSYB's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About PSYBIO THERAP. (SUB.VT.) (PSYB:F) Stock

Stock Target Advisor's fundamental analysis for PSYBIO THERAP. (SUB.VT.)'s stock is Very Bearish.

Unfortunately we do not have enough data on PSYB:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PSYB:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PSYB:F's stock to indicate if its overvalued.

The last closing price of PSYB:F's stock was EUR 0.00.

The most recent market capitalization for PSYB:F is EUR 0.87M.

Unfortunately we do not have enough analyst data on PSYB:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains PSYBIO THERAP. (SUB.VT.)'s stock.

As per our most recent records PSYBIO THERAP. (SUB.VT.) has 0 Employees.

Sorry we do not have any infomation available on PSYBIO THERAP. (SUB.VT.)'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...